SAN DIEGO--(BUSINESS WIRE)--Inovio Biomedical Corporation (AMEX:INO), which is focused on the development of DNA vaccines and a novel solid tumor ablation therapy, announced today it has launched the website www.GeneSwitch.com to provide extensive technical information on Inovio’s gene regulation technology that allows researchers to regulate, via administration of an orally available compound, the intensity and duration of gene expression from genes delivered to cells or animals.
